RSMDF
ResMed Inc.
OTCHealthcareMedical - DevicesUS
Rating:A-
Company Profile
CEO
Michael J. Farrell
IPO Date
2013-03-13
Sector
Healthcare
Industry
Medical - Devices
Exchange
OTC
Country
US
ResMed Inc.
CEO
Michael J. Farrell
IPO Date
2013-03-13
Sector
Healthcare
Industry
Medical - Devices
Exchange
OTC
Country
US
| 3,000 |
| $152.62 |
| 21 Nov 2023 | Burt Carol | director | A-Award | Acquired | 1,768 | $0.00 |
| 20 Nov 2023 | Gill Harjit | director | A-Award | Acquired | 1,768 | $0.00 |
| 20 Nov 2023 | TAYLOR RONALD R | director | A-Award | Acquired | 1,768 | $0.00 |
| 20 Nov 2023 | Farrell Michael J. | Chief Executive Officer | M-Exempt | Acquired | 3,462 | $57.76 |
| 20 Nov 2023 | Farrell Michael J. | Chief Executive Officer | F-InKind | Disposed | 1,343 | $148.90 |
| 20 Nov 2023 | Farrell Michael J. | Chief Executive Officer | F-InKind | Disposed | 2,352.929 | $148.94 |
| 20 Nov 2023 | Farrell Michael J. | Chief Executive Officer | M-Exempt | Disposed | 3,462 | $57.76 |
| 20 Nov 2023 | Farrell Michael J. | Chief Executive Officer | F-InKind | Disposed | 2,352.929 | $148.94 |